Your browser doesn't support javascript.
loading
Cost-of-illness of inflammatory bowel disease patients treated with anti-tumour necrosis factor: A French large single-centre experience.
Lawton, Jean; Achit, Hamza; Pouillon, Lieven; Boschetti, Emmanuelle; Demore, Béatrice; Matton, Thierry; Tournier, Charlène; Prodel, Martin; Peyrin-Biroulet, Laurent; Guillemin, Francis.
Affiliation
  • Lawton J; Department of Hepato-Gastroenterology, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
  • Achit H; CIC 1433 Clinical Epidemiology, Nancy University Hospital, Université de Lorraine, Nancy, France.
  • Pouillon L; Department of Hepato-Gastroenterology, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
  • Boschetti E; Imelda GI Clinical Research Centre, Imeldaziekenhuis Bonheiden, Bonheiden, Belgium.
  • Demore B; Department of Pharmacy, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
  • Matton T; Department of Pharmacy, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
  • Tournier C; Department of Medical Information, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
  • Prodel M; HEVA, Health Economics and Outcomes Research, Lyon, France.
  • Peyrin-Biroulet L; HEVA, Health Economics and Outcomes Research, Lyon, France.
  • Guillemin F; Department of Hepato-Gastroenterology, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
United European Gastroenterol J ; 7(7): 908-913, 2019 08.
Article in En | MEDLINE | ID: mdl-31428415

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Direct Service Costs / Gastrointestinal Agents / Inflammatory Bowel Diseases / Tumor Necrosis Factor-alpha / Cost of Illness / Adalimumab / Infliximab Type of study: Health_economic_evaluation / Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: United European Gastroenterol J Year: 2019 Document type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Direct Service Costs / Gastrointestinal Agents / Inflammatory Bowel Diseases / Tumor Necrosis Factor-alpha / Cost of Illness / Adalimumab / Infliximab Type of study: Health_economic_evaluation / Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: United European Gastroenterol J Year: 2019 Document type: Article Affiliation country: France